BRAIN Biotech AG
LSE:0RFI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BRAIN Biotech AG
LSE:0RFI
|
DE |
|
T
|
Travelers Companies Inc
BMV:TRV
|
US |
|
Royal Bafokeng Platinum Ltd
F:7BF
|
ZA |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
US |
Wall St Price Targets
0RFI Price Targets Summary
BRAIN Biotech AG
According to Wall Street analysts, the average 1-year price target for 0RFI is 6 EUR with a low forecast of 5.4 EUR and a high forecast of 7.3 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RFI's stock price target?
Price Target
6
EUR
According to Wall Street analysts, the average 1-year price target for 0RFI is 6 EUR with a low forecast of 5.4 EUR and a high forecast of 7.3 EUR.
What is the Revenue forecast for BRAIN Biotech AG?
Projected CAGR
6%
Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for BRAIN Biotech AG?
Projected CAGR
9%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 9%.
